Abstract
Laboratory diagnosis of acute hepatitis E virus (HEV) infection typically relies on detecting HEV RNA, IgM, and/or rising IgG levels. However, the temporal profile of these markers in sporadic cases is often misunderstood, leading to potential misdiagnosis. This study analyzed serial sera from 271 acute hepatitis cases to clarify marker dynamics and optimize diagnostic strategies. By tracking these markers over time, the researchers identified that a multi-marker approach is essential for accurate diagnosis, as individual markers like RNA and rising IgG are often missed due to timing.
Introduction
Hepatitis E is a major cause of acute viral hepatitis worldwide. In "sporadic" cases—those not linked to a known outbreak—diagnosis is particularly challenging. Clinical presentation often occurs after the initial viremic phase has subsided or after antibody levels have already reached their peak. Without a clear understanding of the "viremia gap" and antibody kinetics, many infections go undiagnosed. This study sought to map these dynamics to determine the most reliable diagnostic criteria for clinical settings.
Methods and Study Design
The researchers conducted a prospective study in eastern China, analyzing 271 patients who presented with symptoms of acute hepatitis (ALT levels $\ge$ 2.5x the upper limit of normal). A key feature of this study was the collection of serial sera—multiple blood samples taken over the course of the illness—to track how viral markers evolved.
The diagnostic toolkit included:
- RT-PCR for HEV RNA detection.
- ELISA for IgM and IgG antibody quantification.
- IgG Avidity Testing to differentiate between primary infection (low avidity) and re-infection (high avidity).
Key Results and Marker Dynamics
The study identified 91 confirmed cases of hepatitis E. The analysis revealed significant limitations in relying on single-point testing:
- The Viremia Gap: Approximately 23.1% of confirmed cases were negative for HEV RNA at the time of presentation. This suggests that viremia often subsides before patients seek medical attention.
- IgM Robustness: IgM was the most prevalent marker, detected in 90.1% of cases. Its persistence into early convalescence makes it the most reliable single tool for diagnosis at a single point in time.
- Rising IgG Limitations: In 44.0% of cases, a 4-fold rise in IgG was not observed because the antibody levels had already peaked by the first blood draw.
- Re-infection Signatures: Nine cases were IgM-negative but showed rising IgG with high avidity, indicating that re-infection can cause acute illness and requires specific diagnostic attention.
Conclusion
The study demonstrates that no single marker is sufficient to capture all sporadic HEV infections. While IgM is the most sensitive individual marker (90.1%), combining it with RNA and IgG testing reached 100% sensitivity for primary infections in this cohort. For clinical practice, a multi-marker approach is necessary to closely approximate the true occurrence of sporadic hepatitis E and avoid misdiagnosis.
Summary updated